“APIGENIN INCREASES CISPLATIN INHIBITORY EFFECTS ON THE TELOMERASE ACTIVITY OF TRIPLE NEGATIVE BREAST CANCER CELLS”, JT, vol. 80, no. 1, Dec. 2017, doi: 10.11113/jt.v80.10378.